Oncology Times - OncTimes Talk

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development


Listen Later

A tumor-agnostic classifier and screening tool was announced at ESMO Congress 2024 in Barcelona. It was created to make it easier and quicker to develop new drugs that have specific molecular targets, and thus have potential anti-cancer efficacy irrespective of tumor type or location.

The ESMO Tumour-Agnostic Classifier and Screener was the result of work by a multidisciplinary team of international experts led by the ESMO Precision Medicine Working Group. At the conference, Benedikt Westphalen, MD, a medical oncologist and molecular biologist who is Head of the Precision Oncology Program at the University of Munich in Germany, talked about the details with Oncology Times correspondent Peter Goodwin.

...more
View all episodesView all episodes
Download on the App Store

Oncology Times - OncTimes TalkBy

  • 4.3
  • 4.3
  • 4.3
  • 4.3
  • 4.3

4.3

3 ratings


More shows like Oncology Times - OncTimes Talk

View all
Neuro-Oncology: The Podcast by Neuro-Oncology

Neuro-Oncology: The Podcast

12 Listeners

Meet Your Body by Jessica Valant

Meet Your Body

116 Listeners

Oncology Brothers: Practice-Changing Cancer Discussions by Oncology Brothers

Oncology Brothers: Practice-Changing Cancer Discussions

36 Listeners